4) It has been reported that even at low-doses, CDK9 degrader THAL-SNS-032 induced severe gastrointestinal disorders in mouse models due to an on-target off-tumor effect of the compound because of the high expression of CDK9 in the gastrointestinal epithelium. This evidence concerns the gene CDK9 and neoplasm.